关键词: Familial hypercholesterolaemia LDL-Cholesterol target Lipid-lowering therapy PCSK9 inhibitors Very-high risk
Mesh : Anticholesteremic Agents / adverse effects Cardiovascular Diseases Cholesterol, LDL Dyslipidemias Humans Hyperlipoproteinemia Type II / diagnosis drug therapy genetics Proprotein Convertase 9 Risk Factors
来 源:
DOI:10.1016/j.atherosclerosis.2020.07.018
PDF(Sci-hub)